Lv2
194 积分 2024-02-23 加入
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
1天前
已完结
Uridine depletion impairs CD8⁺ T cell antitumor activity through N-glycosylation
1天前
已完结
The complex role of tumor-infiltrating macrophages
1个月前
已完结
Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism
1个月前
已完结
The metabolic fate of acetate in cancer
1个月前
已完结
Phase 1 Combination Study of the CHK1 Inhibitor Prexasertib and the PARP Inhibitor Olaparib in High-grade Serous Ovarian Cancer and Other Solid Tumors
4个月前
已完结
Cell cycle checkpoints and beyond: Exploiting the ATR/CHK1/WEE1 pathway for the treatment of PARP inhibitor–resistant cancer
4个月前
已完结
Blocking c-Met–mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors
4个月前
已完结
Blocking c-Met–mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors
4个月前
已完结
UFL1 triggers replication fork degradation by MRE11 in BRCA1/2-deficient cells
4个月前
已完结
皖公网安备34019202002308
